Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triptorelin dosing in endometriosis cysts
NCT06525155Phase 3Recruiting
- Sponsor
- Gatot Soebroto Central Army Hospital
- Start
- Jan 2024
- Primary completion
- Feb 2025
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of triptorelin in endometriosis, sponsored by Gatot Soebroto Central Army Hospital. Started Jan 2024; status: recruiting.
02
Drugs
triptorelin
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT06525155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06525155.